Our latest research work “Therapeutic potential of chemically modified, synthetic, triplex peptide nucleic acid-based oncomiR inhibitors for cancer therapy” got featured on the cover page of Cancer Research Journal, Vol 81, Issue 22, November 2021. Check out the cover page here!